{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:41:12Z","timestamp":1794285672090,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH101874"],"award-info":[{"award-number":["MH101874"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH122379"],"award-info":[{"award-number":["MH122379"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH101874"],"award-info":[{"award-number":["MH101874"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH123748"],"award-info":[{"award-number":["MH123748"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH122379"],"award-info":[{"award-number":["MH122379"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"DOI":"10.13039\/100013395","name":"WUSTL | Washington University School of Medicine in St. Louis | Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013395","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bantly Foundaton is a private foundation."},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Certain selective serotonin reuptake inhibitors (SSRIs) have anti-inflammatory effects in preclinical models, and recent clinical studies suggest that fluvoxamine can prevent deterioration in patients with COVID-19, possibly through activating sigma 1 receptors (S1Rs). Here we examined potential mechanisms contributing to these effects of fluvoxamine and other SSRIs using a well-characterized model of pro-inflammatory stress in rat hippocampal slices. When hippocampal slices are exposed acutely to lipopolysaccharide (LPS), a strong pro-inflammatory stimulus, basal synaptic transmission in the CA1 region remains intact, but induction of long-term potentiation (LTP), a form of synaptic plasticity thought to contribute to learning and memory, is completely disrupted. Administration of low micromolar concentrations of fluvoxamine and fluoxetine prior to and during LPS administration overcame this LTP inhibition. Effects of fluvoxamine required both activation of S1Rs and local synthesis of 5-alpha reduced neurosteroids. In contrast, the effects of fluoxetine did not involve S1Rs but required neurosteroid production. The ability of fluvoxamine to modulate LTP and neurosteroid production was mimicked by a selective S1R agonist. Additionally, fluvoxamine and fluoxetine prevented learning impairments induced by LPS in vivo. Sertraline differed from the other SSRIs in blocking LTP in control slices likely via S1R inverse agonism. These results provide strong support for the hypothesis that S1Rs and neurosteroids play key roles in the anti-inflammatory effects of certain SSRIs and that these SSRIs could be beneficial in disorders involving inflammatory stress including psychiatric and neurodegenerative illnesses.<\/jats:p>","DOI":"10.1038\/s41398-023-02343-3","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T15:04:04Z","timestamp":1675436644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids"],"prefix":"10.1038","volume":"13","author":[{"given":"Yukitoshi","family":"Izumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-4590","authenticated-orcid":false,"given":"Angela M.","family":"Reiersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lenze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-0664","authenticated-orcid":false,"given":"Steven J.","family":"Mennerick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9704-5154","authenticated-orcid":false,"given":"Charles F.","family":"Zorumski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/a-1686-9620","volume":"55","author":"MJ Nykamp","year":"2022","unstructured":"Nykamp MJ, Zorumski CF, Reiersen AM, Nicol GS, Cirrito J, Lenze EJ. Opportunities for drug repurposing of serotonin reuptake inhibitors: potential uses in inflammation, infection, cancer, neuroprotection and Alzheimer\u2019s disease prevention. Pharmacopsychiatry 2022;55:24\u201329.","journal-title":"Pharmacopsychiatry"},{"key":"2343_CR2","doi-asserted-by":"publisher","first-page":"652688","DOI":"10.3389\/fphar.2021.652688","volume":"12","author":"VP Sukhatme","year":"2021","unstructured":"Sukhatme VP, Reiersen AM, Vayttaden SJ, Sukhatme VV. Fluvoxamine: a review of its mechanism of action and its role in COVID-19. Front Pharm. 2021;12:652688. https:\/\/doi.org\/10.3389\/fphar.2021.652688.","journal-title":"Front Pharm"},{"key":"2343_CR3","doi-asserted-by":"publisher","first-page":"2102975118","DOI":"10.1073\/pnas.2102975118","volume":"118","author":"M Ambati","year":"2021","unstructured":"Ambati M, Apicella I, Wang S-B, Narendran S, Leuing H, Pereira F, et al. Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration. Proc Natl Acad Sci USA 2021;118:2102975118. https:\/\/doi.org\/10.1073\/pnas.2102975118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1085\/jgp.201812263","volume":"151","author":"R Kapoor","year":"2019","unstructured":"Kapoor R, Peyear TA, Koeppe RE, Andersen OS. Antidepressants are modifiers of lipid bilayer properties. J Gen Physiol. 2019;151:342\u201356.","journal-title":"J Gen Physiol"},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.biopsych.2012.05.020","volume":"72","author":"HA Lester","year":"2012","unstructured":"Lester HA, Miwa JM, Srinivasan R. Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects. Biol Psychiatry. 2012;72:907\u201315.","journal-title":"Biol Psychiatry"},{"key":"2343_CR6","doi-asserted-by":"publisher","first-page":"737509","DOI":"10.3389\/fnins.2021.737509","volume":"15","author":"L Yang","year":"2021","unstructured":"Yang L, Chen ZH, Li J, Ding PJ, Wang Y. Effects of escitalopram on endoplasmic reticulum stress and oxidative stress induced by tunicamycin. Front Neurosci. 2021;15:737509. https:\/\/doi.org\/10.3389\/fnins.2021.737509.","journal-title":"Front Neurosci"},{"key":"2343_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-0773.1997.tb00285.x","volume":"80","author":"WA Daniel","year":"1997","unstructured":"Daniel WA, Wojcikowski J. Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharm Toxicol. 1997;80:62\u201368.","journal-title":"Pharm Toxicol"},{"key":"2343_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2014.01.064","volume":"727","author":"T Ishima","year":"2014","unstructured":"Ishima T, Fujita Y, Hashimoto K. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. Eur J Pharm. 2014;727:167\u201373.","journal-title":"Eur J Pharm"},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/s41380-018-0090-9","volume":"23","author":"A Gulbins","year":"2018","unstructured":"Gulbins A, Schumacher F, Becker KA, Wilker B, SoddemannM, Boldrin F, et al. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide. Mol Psychiatry. 2018;23:2324\u201346.","journal-title":"Mol Psychiatry"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","volume":"96","author":"LD Griffin","year":"1999","unstructured":"Griffin LD, Mellon SH. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 1999;96:13512\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1124\/jpet.112.198168","volume":"343","author":"K-SC Marriott","year":"2012","unstructured":"Marriott K-SC, Prasad M, Thapliyal V, Bose HS. \u03c3-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation. JPET 2012;343:578\u201386.","journal-title":"JPET"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1038\/cddis.2014.301","volume":"5","author":"T Omi","year":"2014","unstructured":"Omi T, Tanimukai H, Kanayama D, Sakagami Y, Tagami S, Okochi M, et al. Fluvoxamine alleviates ER stress via induction of slgma-1 receptor. Cell Death Dis. 2014;5:e1332. https:\/\/doi.org\/10.1038\/cddis.2014.301.","journal-title":"Cell Death Dis"},{"key":"2343_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coph.2008.12.006","volume":"9","author":"G Pinna","year":"2009","unstructured":"Pinna G, Costa E, Guidotti A. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharm. 2009;9:24\u201330.","journal-title":"Curr Opin Pharm"},{"key":"2343_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bjorkholm","year":"2016","unstructured":"Bjorkholm C, Monteggia LM. BDNF \u2013 a key transducer of antidepressant effects. Neuropharmacology 2016;102:72\u201379.","journal-title":"Neuropharmacology"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cell.2021.01.034","volume":"184","author":"PC Casarotto","year":"2021","unstructured":"Casarotto PC, Girych M, Fred SM, Koveleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TrkB neurotrophin receptors. Cell 2021;184:1\u201315.","journal-title":"Cell"},{"key":"2343_CR16","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ajpath.2014.03.014","volume":"184","author":"E Barbero-Camps","year":"2014","unstructured":"Barbero-Camps E, Fernandez A, Baulies A, Martinez L, Fernandez-Checa JC, Colell A. Endoplasmic reticulum stress mediates amyloid \u03b2 neurotoxicity via mitochondrial cholesterol trafficking. Am J Pathol. 2014;184:2066\u201381.","journal-title":"Am J Pathol"},{"key":"2343_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-017-0389-6","volume":"24","author":"T-Y Weng","year":"2017","unstructured":"Weng T-Y, Tsai S-YA, Su T-S. Roles of sigma-1 receptor on mitochondrial functions relevant to neurodegenerative diseases. J Biomed Sci. 2017;24:74. https:\/\/doi.org\/10.1186\/s12929-017-0389-6.","journal-title":"J Biomed Sci"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fphar.2018.00711","volume":"9","author":"A Tesei","year":"2018","unstructured":"Tesei A, Cortesi M, Zamagni A, Arienti C, Pignatta S, Zanoni M, et al. Sigma receptors as endoplasmic reticulum stress \u201cgatekeepers\u201d and their modulators as emerging new weapons in the fight against cancer. Front Pharm. 2018;9:711. 10.3389.fphar.2013.00711","journal-title":"Front Pharm"},{"key":"2343_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fnins.2019.00733","volume":"13","author":"T Hayashi","year":"2019","unstructured":"Hayashi T. The sigma-1 receptor in cellular stress signaling. Front Neurosci. 2019;13:733. https:\/\/doi.org\/10.3389\/fnins.2019.00733.","journal-title":"Front Neurosci"},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.tips.2019.07.006","volume":"40","author":"HR Schmidt","year":"2019","unstructured":"Schmidt HR, Kruse AC. The molecular function of sigma receptors: past, present and future. Trends Pharm Sci. 2019;40:636\u201354.","journal-title":"Trends Pharm Sci"},{"key":"2343_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphar.2019.00419","volume":"10","author":"SL Morales-Lazaro","year":"2019","unstructured":"Morales-Lazaro SL, Gonzalez-Ramirez R, Rosenbaum T. Molecular interplay between sigma-1 receptor, steroids, and ion channels. Front Pharm. 2019;10:419. https:\/\/doi.org\/10.3389\/fphar.2019.00419.","journal-title":"Front Pharm"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","volume":"63","author":"N Ye","year":"2020","unstructured":"Ye N, Qin W, Tian S, Xu Q, Wold EA, Zhou J, et al. Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases. J Med Chem. 2020;63:15187\u2013217.","journal-title":"J Med Chem"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jphs.2014.11.010","volume":"127","author":"K Hashimoto","year":"2015","unstructured":"Hashimoto K. Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. J Pharm Sci. 2015;127:6\u20139.","journal-title":"J Pharm Sci"},{"key":"2343_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0893-133X(00)00116-0","volume":"23","author":"NR Bolo","year":"2000","unstructured":"Bolo NR, Hode Y, Nedelec J-F, Laine E, Wagner G, Macher J-P. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 2000;23:428\u201338.","journal-title":"Neuropsychopharmacology"},{"key":"2343_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.biopsych.2007.04.001","volume":"62","author":"M Ishikawa","year":"2007","unstructured":"Ishikawa M, Ishiwata K, Ishii K, Kimura Y, Sakata M, Naganawa M, et al. High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry. 2007;62:878\u201383.","journal-title":"Biol Psychiatry"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"eaau5266","DOI":"10.1126\/scitranslmed.aau5266","volume":"11","author":"DA Rosen","year":"2019","unstructured":"Rosen DA, Seki SM, Fernandez-Castaneda A, Beiter RM, Eccles JD, Woodfold JA, et al. Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis. Sci Transl Med. 2019;11:eaau5266.","journal-title":"Sci Transl Med"},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2020.22760","volume":"324","author":"EJ Lenze","year":"2020","unstructured":"Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE, et al. Fluvoxamine for prevention of clinical deterioration in outpatients with COVID-19: a randomized clinical trial. J Am Med Assoc. 2020;324:2292\u20132300.","journal-title":"J Am Med Assoc."},{"key":"2343_CR28","doi-asserted-by":"publisher","first-page":"ofab050","DOI":"10.1093\/ofid\/ofab050","volume":"8","author":"D Seftel","year":"2021","unstructured":"Seftel D, Boulware DR. Prospective cohort of fluvoxamine for early treatment coronavirus disease 19. Open Forum Infect Dis. 2021;8:ofab050. 10\/1093\/ofid\/ofab050","journal-title":"Open Forum Infect Dis"},{"key":"2343_CR29","doi-asserted-by":"publisher","unstructured":"Reis G, Moreira-Silva AS, Silva DCM, Thabane L, Milagres AC, Ferreira TS, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Global Health. 2021; https:\/\/doi.org\/10.1016\/S2214-109X(21)00448-4.","DOI":"10.1016\/S2214-109X(21)00448-4"},{"key":"2343_CR30","first-page":"290","volume":"10","author":"OME Abdel-Salam","year":"2011","unstructured":"Abdel-Salam OME, Morsy SMY, Sleem AA. The effect of different antidepressant drugs on oxidative stress after lipopolysaccharide administration in mice. EXCLI J. 2011;10:290\u2013302.","journal-title":"EXCLI J"},{"key":"2343_CR31","doi-asserted-by":"publisher","first-page":"10054","DOI":"10.1523\/JNEUROSCI.1502-21.2021","volume":"41","author":"Y Izumi","year":"2021","unstructured":"Izumi Y, Cashikar A, Krishnan K, Paul SM, Covey DF, Mennerick SJ, et al. A pro-inflammatory stimulus disrupts hippocampal plasticity and learning via microglial activation and 25-hydroxycholesterol. J Neurosci. 2021;41:10054\u201364.","journal-title":"J Neurosci"},{"key":"2343_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbi.2011.12.011","volume":"26","author":"RJ Tynan","year":"2012","unstructured":"Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microgliia. Brain Behav Immun. 2012;26:469\u201379.","journal-title":"Brain Behav Immun"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"9905","DOI":"10.1523\/JNEUROSCI.1660-11.2011","volume":"31","author":"K Tokuda","year":"2011","unstructured":"Tokuda K, Izumi Y, Zorumski CF. Ethanol enhances neurosteroidogenesis in hippocampal pyramidal neurons by paradoxical NMDA receptor activation. J Neurosci. 2011;31:9905\u20139.","journal-title":"J Neurosci"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"16788","DOI":"10.1523\/JNEUROSCI.4101-10.2010","volume":"30","author":"K Tokuda","year":"2010","unstructured":"Tokuda K, O\u2019Dell KA, Izumi Y, Zorumski CF. Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis. J Neurosci. 2010;30:16788\u201395.","journal-title":"J Neurosci"},{"key":"2343_CR35","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1126\/science.1128134","volume":"313","author":"JR Whitlock","year":"2006","unstructured":"Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation in the hippocampus. Science 2006;313:1093\u20137.","journal-title":"Science"},{"key":"2343_CR36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bbrc.2013.04.055","volume":"434","author":"Y Ono","year":"2013","unstructured":"Ono Y, Tanaka H, Tsuruma K, Shimazawa S, Hara H. A sigma-1 receptor antagonist (NE-100) prevents tunicamycin-induced cell death via GRP78 induction in hippocampal cells. Biochem Biophys Res Commun. 2013;434:904\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2343_CR37","doi-asserted-by":"publisher","first-page":"105803","DOI":"10.1016\/j.biocel.2020.105803","volume":"126","author":"ZY Motawe","year":"2020","unstructured":"Motawe ZY, Abdelmaboud SS, Cuevas J, Breslin JW. PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation. Int J Biochem Cell Biol. 2020;126:105803. https:\/\/doi.org\/10.1016\/j.biocel.2020.105803.","journal-title":"Int J Biochem Cell Biol"},{"key":"2343_CR38","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1073\/pnas.0337642100","volume":"100","author":"G Pinna","year":"2003","unstructured":"Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A. In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci USA 2003;100:2035\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2343_CR39","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","volume":"95","author":"V Uzunova","year":"1998","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998;95:3239\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2343_CR40","doi-asserted-by":"publisher","first-page":"14602","DOI":"10.1073\/pnas.0606544103","volume":"103","author":"RC Agis-Balboa","year":"2006","unstructured":"Agis-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, Costa E, et al. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA 2006;103:14602\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2343_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.psyneuen.2012.06.008","volume":"38","author":"MP Castelli","year":"2013","unstructured":"Castelli MP, Casti A, Casu A, Frau R, Bortolato M, Spiga S, et al. Regional distribution of 5\u03b1-reductase type 2 in the adult rat brain: an immunohistochemical analysis. Psychoneuroendocrinol. 2013;38:281\u201393.","journal-title":"Psychoneuroendocrinol"},{"key":"2343_CR42","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1210\/jc.2003-030330","volume":"89","author":"RV Clark","year":"2004","unstructured":"Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5 alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89:2179\u201384.","journal-title":"J Clin Endocrinol Metab"},{"key":"2343_CR43","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.neubiorev.2011.12.011","volume":"36","author":"CF Zorumski","year":"2012","unstructured":"Zorumski CF, Izumi Y. NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders. Neurosci Biobehav Rev. 2012;36:989\u20131000.","journal-title":"Neurosci Biobehav Rev"},{"key":"2343_CR44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2201662","volume":"387","author":"CT Bramante","year":"2022","unstructured":"Bramante CT, Huling J, Tignanelli CJ, Buse JB, Liebovitz DM, Nacklas JM, et al. Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19. N. Engl J Med. 2022;387:599\u2013610.","journal-title":"N. Engl J Med"},{"key":"2343_CR45","doi-asserted-by":"publisher","first-page":"e2133090","DOI":"10.1001\/jamanetworkopen.2021.33090","volume":"4","author":"T Oskotsky","year":"2021","unstructured":"Oskotsky T, Maric I, Tang A, Oskotsky B, Wong RJ, Aghaeeour N, et al. Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open. 2021;4:e2133090. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.33090.","journal-title":"JAMA Netw Open"},{"key":"2343_CR46","first-page":"322","volume":"5","author":"CN Karson","year":"1993","unstructured":"Karson CN, Newton JEO, Livingston R, Jolly JB, Cooper TB, Sprigg J, et al. Human brain fluoxetine concentrations. J Neuropsych. Clin Neurosci. 1993;5:322\u20139.","journal-title":"Clin Neurosci"},{"key":"2343_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01266-1","volume":"11","author":"I Balan","year":"2021","unstructured":"Balan I, Aurelian L, Schleicher R, Boero G, O\u2019Buckley T, Morrow AL. Neurosteroid allopregnanolone (3\u03b1,5\u03b1-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors. Transl Psychiatry. 2021;11:145. https:\/\/doi.org\/10.1038\/s41398-021-01266-1.","journal-title":"Transl Psychiatry"},{"issue":"Dec","key":"2343_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37409-6","volume":"9","author":"I Balan","year":"2019","unstructured":"Balan I, Beattie MC, O\u2019Buckley TK, Aurelian L, Morrow AL. Endogenous neurosteroid (3\u03b1,5\u03b1)3-hydroxypregnan-20-one inhibits toll-like-4 receptor activation and pro-inflammatory signaling in macrophages and brain. Sci Rep. 2019;9(Dec):1220.","journal-title":"Sci Rep"},{"key":"2343_CR49","doi-asserted-by":"publisher","first-page":"8531","DOI":"10.1167\/iovs.14-15624","volume":"55","author":"M Ishikawa","year":"2014","unstructured":"Ishikawa M, Yoshitomi T, Zorumski CF, Izumi Y. Neurosteroids are endogenous neuroprotectants in an ex vivo glaucoma model. Invest Ophthalmol Vis Sci. 2014;55:8531\u201341.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2343_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0960-0760(97)00002-2","volume":"61","author":"B Azzolina","year":"1997","unstructured":"Azzolina B, Ellsworth K, Andersson S, Geissler W, Bull HG, Harris GS. Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol. 1997;61:55\u201364.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2343_CR51","first-page":"1","volume":"2","author":"JJ Liang","year":"2018","unstructured":"Liang JJ, Rasmussen AM. Overview of the molecular steps in steroidogenesis of the GABAergic neurosteroids allopregnanolone and pregnanolone. Chronic. Stress 2018;2:1\u201317.","journal-title":"Stress"},{"key":"2343_CR52","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1021\/bi026109w","volume":"41","author":"JW Trauger","year":"2002","unstructured":"Trauger JW, Jiang A, Stearns BA, LoGrasso PV. Kinetics of allopregnanolone formation catalyzed by human 3\u03b1-hydroxysteroid dehydrogenase type III (AKR1C2). Biochemistry 2002;41:13451\u20139.","journal-title":"Biochemistry"},{"key":"2343_CR53","doi-asserted-by":"publisher","first-page":"855779","DOI":"10.3389\/fphar.2022.855779","volume":"13","author":"M Ishikawa","year":"2022","unstructured":"Ishikawa M, Nakazawa T, Kunikata H, Sato K, Yoshitomi T, Krishnan K, et al. The enantiomer of allopregnanolone prevents pressure-mediated retinal degeneration via autophagy. Front Pharmacol. 2022;13:855779. https:\/\/doi.org\/10.3389\/fphar.2022.855779.","journal-title":"Front Pharmacol."},{"key":"2343_CR54","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/15548627.2020.1731270","volume":"17","author":"M Ishikawa","year":"2021","unstructured":"Ishikawa M, Takaseki S, Yoshitomi T, Covey DF, Zorumski CF, Izumi Y. The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs\/GABAA receptors in rat glaucoma models. Autophagy 2021;17:743\u201360.","journal-title":"Autophagy"},{"key":"2343_CR55","doi-asserted-by":"publisher","first-page":"100196","DOI":"10.1016\/j.ynstr.2019.10096","volume":"11","author":"CF Zorumski","year":"2019","unstructured":"Zorumski CF, Paul SM, Covey DF, Mennerick S. Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond. Neurobiol Stress 2019;11:100196. https:\/\/doi.org\/10.1016\/j.ynstr.2019.10096.","journal-title":"Neurobiol Stress"},{"key":"2343_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2019.03.032","volume":"853","author":"Y Matsushima","year":"2019","unstructured":"Matsushima Y, Terada K, Kamei C, Sugimoto Y. Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor. Eur J Pharmacol. 2019;853:129\u201335.","journal-title":"Eur J Pharmacol."},{"key":"2343_CR57","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.neuropharm.2012.10.002","volume":"67","author":"FR Walker","year":"2013","unstructured":"Walker FR. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 2013;67:304\u201317.","journal-title":"Neuropharmacology"},{"key":"2343_CR58","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s12035-014-8923-2","volume":"52","author":"S Moriguchi","year":"2015","unstructured":"Moriguchi S, Sakagami H, Yabuki Y, Sasaki Y, Izumi H, Zhang C, et al. Stimulation of sigma-1 receptor ameliorates depressive-like behaviors in CaMKIV null mice. Mol Neurobiol. 2015;52:1210\u201322.","journal-title":"Mol Neurobiol."},{"key":"2343_CR59","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nn.3355","volume":"16","author":"X Cai","year":"2013","unstructured":"Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM, et al. Local potentiation of excitatory synapses by serotonin and it alteration in rodent models of depression. Nat Neurosci. 2013;16:464\u201372.","journal-title":"Nat Neurosci."},{"key":"2343_CR60","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","volume":"38","author":"SM Thompson","year":"2015","unstructured":"Thompson SM, Kallarackal AJ, Kvarta MD, Van Dyke AM, LeGates TA, Cai X. An excitatory synapse hypothesis of depression. Trend Neurosci. 2015;38:279\u201394.","journal-title":"Trend Neurosci."},{"key":"2343_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuropharm.2019.03.005","volume":"150","author":"AM Van Dyke","year":"2019","unstructured":"Van Dyke AM, Francis TC, Chen H, Bailey AM, Thompson SM. Chronic fluoxetine treatment in vivo enhances excitatory synaptic transmission in the hippocampus. Neuropharmacology 2019;150:38\u201345.","journal-title":"Neuropharmacology"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02343-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T21:03:10Z","timestamp":1675544590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02343-3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CFZ serves on the Scientific Advisory Board of Sage Therapeutics and has equity in Sage Therapeutics. Sage Therapeutics did not fund this research. AMR and EJL have a patent pending on methods of treating COVID-19, including fluvoxamine. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}